Literature DB >> 14689452

Astrocytes in culture require docosahexaenoic acid to restore the n-3/n-6 polyunsaturated fatty acid balance in their membrane phospholipids.

Gaëlle Champeil-Potokar1, Isabelle Denis, Bénédicte Goustard-Langelier, Jean-Marc Alessandri, Philippe Guesnet, Monique Lavialle.   

Abstract

Docosahexaenoic acid (DHA), the main n-3 polyunsaturated fatty acid (PUFA) in membranes, is particularly abundant in brain cells. Decreased cerebral concentrations of DHA, resulting from dietary n-3 deficiency, are associated with impaired cognitive function. Because the cellular causes of this impairment are still unknown, we need in vitro models that mimic the variations in n-3/n-6 PUFA seen in vivo. We have compared the PUFA profiles of hamster astrocytes cultured in medium supplemented with long-chain PUFA [DHA and/or arachidonic acid (AA)] with those of brain tissue from hamsters fed an n-6/n-3 PUFA-balanced diet or one lacking n-3 PUFA. Astrocytes were obtained from the brain cortex of newborn hamsters and cultured in minimum essential medium + 5% fetal calf serum (FCS) supplemented with DHA and/or AA for 10 days. The astrocytes cultured in medium + FCS had low n-3 PUFA contents, comparable to those of brain tissue from hamsters fed an n-3-deficient diet. We have shown that astrocytes grown in medium supplemented with DHA and/or AA, plus alpha-tocopherol to prevent lipid peroxidation, incorporated large amounts of these long-chain PUFA, so that the n-6/n-3 PUFA compositions of the phosphatidylethanolamine and phosphatidylcholine, the two main classes of membrane phospholipids, were greatly altered. Astrocytes cultured in medium plus DHA had a more physiological n-3 status, grew better, and retained their astrocyte phenotype. Thus astrocytes in culture are likely to be physiologically relevant only when provided with adequate DHA. This reliable method of altering membrane phospholipid composition promises to be useful for studying the influence of n-6/n-3 imbalance on astrocyte function. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14689452     DOI: 10.1002/jnr.10817

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Effect of dietary docosahexaenoic acid on rhodopsin content and packing in photoreceptor cell membranes.

Authors:  Subhadip Senapati; Megan Gragg; Ivy S Samuels; Vipul M Parmar; Akiko Maeda; Paul S-H Park
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-04       Impact factor: 3.747

2.  Nutrient intake and cerebral metabolism in healthy middle-aged adults: Implications for cognitive aging.

Authors:  Stephanie Oleson; Mitzi M Gonzales; Takashi Tarumi; Jaimie N Davis; Carolyn K Cassill; Hirofumi Tanaka; Andreana P Haley
Journal:  Nutr Neurosci       Date:  2016-05-30       Impact factor: 4.994

3.  Glutamate homeostasis in the adult rat prefrontal cortex is altered by cortical docosahexaenoic acid accrual during adolescence: An in vivo1H MRS study.

Authors:  Robert K McNamara; Ruth H Asch; Jennifer D Schurdak; Diana M Lindquist
Journal:  Psychiatry Res Neuroimaging       Date:  2017-10-11       Impact factor: 2.376

Review 4.  Omega-3 fatty acids and cognitive function in women.

Authors:  Jennifer G Robinson; Nkechinyere Ijioma; William Harris
Journal:  Womens Health (Lond)       Date:  2010-01

5.  FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation.

Authors:  Kazem Sharifi; Yusuke Morihiro; Motoko Maekawa; Yuki Yasumoto; Hisae Hoshi; Yasuhiro Adachi; Tomoo Sawada; Nobuko Tokuda; Hisatake Kondo; Takeo Yoshikawa; Michiyasu Suzuki; Yuji Owada
Journal:  Histochem Cell Biol       Date:  2011-09-22       Impact factor: 4.304

6.  Alterations in neuronal morphology and synaptophysin expression in the rat brain as a result of changes in dietary n-6: n-3 fatty acid ratios.

Authors:  Toktam Hajjar; Yong Meng Goh; Mohamed Ali Rajion; Sharmili Vidyadaran; Tan Ai Li; Mahdi Ebrahimi
Journal:  Lipids Health Dis       Date:  2013-07-26       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.